Seo, E.S.; Lee, E.-j.; Lee, B.; Shin, M.; Cho, Y.-S.; Hyun, J.K.; Cho, H.W.; Ju, H.Y.; Yoo, K.H.; Koo, H.H.;
et al. Metastatic Burden Defines Clinically and Biologically Distinct Subgroups of Stage 4 High-Risk Neuroblastoma. J. Clin. Med. 2020, 9, 2730.
https://doi.org/10.3390/jcm9092730
AMA Style
Seo ES, Lee E-j, Lee B, Shin M, Cho Y-S, Hyun JK, Cho HW, Ju HY, Yoo KH, Koo HH,
et al. Metastatic Burden Defines Clinically and Biologically Distinct Subgroups of Stage 4 High-Risk Neuroblastoma. Journal of Clinical Medicine. 2020; 9(9):2730.
https://doi.org/10.3390/jcm9092730
Chicago/Turabian Style
Seo, Eun Seop, Eun-jin Lee, Boram Lee, Muheon Shin, Young-Seok Cho, Ju Kyung Hyun, Hee Won Cho, Hee Young Ju, Keon Hee Yoo, Hong Hoe Koo,
and et al. 2020. "Metastatic Burden Defines Clinically and Biologically Distinct Subgroups of Stage 4 High-Risk Neuroblastoma" Journal of Clinical Medicine 9, no. 9: 2730.
https://doi.org/10.3390/jcm9092730
APA Style
Seo, E. S., Lee, E.-j., Lee, B., Shin, M., Cho, Y.-S., Hyun, J. K., Cho, H. W., Ju, H. Y., Yoo, K. H., Koo, H. H., Lee, J. W., & Sung, K. W.
(2020). Metastatic Burden Defines Clinically and Biologically Distinct Subgroups of Stage 4 High-Risk Neuroblastoma. Journal of Clinical Medicine, 9(9), 2730.
https://doi.org/10.3390/jcm9092730